{"schema_version":"secwatch.filing_event.v1","accession":"0001872789-23-000011","form_type":"8-K","ticker":"EMBC","cik":"0001872789","company_name":"Embecta Corp.","filed_at":"2023-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.412750+00:00","generated_at":"2026-06-15T02:51:51.491485+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Embecta beats Q2 with $277M revenue (+4% CC); raises FY2023 adj EPS guidance to $2.50-$2.60","bullets":["Q2 revenue $277.1M, +4.0% constant currency; US +3.6%, international +4.4% constant currency.","Adjusted EPS $0.75, adjusted operating margin 30.6%, adjusted EBITDA margin 34.9%.","FY2023 guidance raised: revenue $1,101-1,113M (prev $1,084-1,107M), constant currency growth 0-1%.","Adjusted EPS guidance raised to $2.50-2.60 from $2.20-2.35; adj gross margin ~64.5%, adj op margin ~28%.","Declared $0.15/share quarterly dividend; advancing insulin patch pump via Tidepool collaboration for type 2 closed-loop."],"urls":{"canonical":"https://secwatch.observer/filing/0001872789-23-000011","json":"https://secwatch.observer/filing/0001872789-23-000011.json","markdown":"https://secwatch.observer/filing/0001872789-23-000011.md","text":"https://secwatch.observer/filing/0001872789-23-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872789/000187278923000011/0001872789-23-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872789/000187278923000011/embc-20230512.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T02:51:51.491485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab5c2971c70d2ede3aebce1a91443eb49feaa8f1","claim":"Embecta Corp. reported second quarter fiscal 2023 results: revenue $277.1 million, net income $14.0 million, EPS $0.24. Guidance raised.","evidence_excerpt":"for the three and six-month periods ended March 31, 2023 and March 31, 2022 are not meaningfully comparable. Second Quarter Fiscal Year 2023 Financial Highlights : • Revenues of $277.1 million, up 0.9% on a reported basis; up 4.0% on a constant currency basis ◦ U.S. revenues increased 3.6% on both a reported and constant currency basis ◦ International revenues","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1872789/000187278923000011/0001872789-23-000011-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter fiscal 2023"},{"label":"Revenue","value":"$277.1 million"},{"label":"Net income","value":"$14.0 million"},{"label":"EPS","value":"$0.24"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}